ISSN: 2165-7920
Journal of Clinical Case Reports
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Congenital Chylothorax: Management and Long-term Outcome A Case Report and Literature Review

Salma Ben Ameur*
Department of pediatrics Hedi Chaker Hospital, El Ainstreet, Tunisia
Corresponding Author : Salma Ben Ameur
Department of pediatrics Hedi Chaker Hospital
El Ain Street Km 0.5; 3029 Sfax Tunisia
Tel: 0021698429490
Fax: 0021674249157
E-mail: benameursalma@gmail.com
Received: November 06, 2015; Accepted: December 11, 2015; Published: December 18, 2015
Citation: Ameur SB (2015) Congenital Chylothorax: Management and Longterm Outcome A Case Report and Literature Review. J Clin Case Rep 5:668. doi:10.4172/2165-7920.1000668
Copyright: © 2015 Ameur SB. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at Pubmed, Scholar Google

Visit for more related articles at Journal of Clinical Case Reports

Abstract

Congenital chylothorax is the most common cause of pleural effusion in the neonatal period. We describe a 9 days old new born admitted for respiratory distress. The chest X-rays showed a white right lung with a left mediastinal shift. A pleural aspiration assessed the diagnosis of chylothorax. Lympho-scintigraphy detected rapid drainage of lymph into the right side of the chest. A conservative treatment was initiated with pleural aspirations and total parenteral nutrition followed by enteral feeding using semi elemental formula. This treatment was effective and the child was discharged from the hospital at the age of 40 days. A 6 years follow-up, revealed no recurrence of the chylothorax.

Keywords
Congenital chylothorax; Pleural effusion; Respiratory distress
Introduction
Congenital Chylothorax (CT), defined, as the accumulation of lymphatic fluid in the pleural cavity, is a rare neonatal disorder. Nevertheless, congenital chylothorax represents the most common cause of pleural effusion in fetuses and newborn [1]. Chylothorax may lead to high morbidity and may even threaten survival, because of respiratory distress and large losses of lymphocytes, proteins, and immunoglobulins. The treatment options of congenital chylothorax are still controversial [1,2]. Here, we report a new case of idiopathic congenital chylothrax and discuss the different therapeutic approaches and neonatal and the long term outcome.
Case Report
M.., a female new born, was admitted at the age of 9 days for respiratory distress. She was born by normal vaginal delivery at full term pregnancy, which was poorly monitored. The birth weight was 3400 g, and the Apgar scores were 7 at 1 minute and 8 at 5 minute. The parents were non consanguineous and there were no hereditary disorders in family history.
On examination, the temperature was 37.5°C, the pulse 150 beats per minute, the respiratory rate 80 breaths per minute, and the oxygen saturation 88% in room air an removed to 95% after supplemental oxygen. The infant appeared tachypneic and groaned. Auscultation revealed decreased breath sounds on the right. There was no dysmorphic features and the remainder of physical examination were unremarkable.
The chest X-rays showed a white right lung with a left mediastinal shift (Figure 1). The chest scan revealed an important right pleural effusion. Thoracocentesis yielded milky fluid suggestive of chylothorax. (Figure 2).
Pleural fluid analysis showed 1200 white blood cells/mm3 with 80% lymphocytes, 73 g/l of protein, 3.9 mmol/l of cholesterol and 20.55 mmol/l of triglycerides. The culture was negative. Blood count showed a hemoglobin of 15 g/dl, white blood cell count of 20000/mm3 with 67% neutrophils, 30% lymphocytes. Other laboratory investigations revealed normal blood urea nitrogen, creatinine, electrolytes, triglyceride (1.12 mmol/l) and cholesterol (3.9 mmol/l).
Cardiac ultrasound was normal. Radionuclide lymphoscintigraphy using 99m-technetium (99m-Tc) confirmed normal lymphatic anatomy, but also detected rapid drainage of lymph into the right side of the chest.
The infant was started on total parenteral nutrition. Because of increasing tachypnoea, thoracocentesis was repeated on the 10 th day after admission and extracted a volume of 60 ml. Improvement of respiratory distress was so noted. Follow-up chest X-ray revealed decrease in the pleural effusion. Enteral feeding, using a semi elemental formula (peptujinior®) was then initiated after 15 days. Control‘s scintigraphy showed normal opacification of the thoracic duct.
The child was discharged from the hospital at the age of 40 days. Her growth and development were appropriate for her age on subsequent follow-up. The chromosome analysis revealed normal female karyotype. A 6 years follow-up, revealed no recurrence of the chylothorax with a normal growth and psychomotor development.
Discussion
Chylothorax is a rare disease (1-2% of pleural effusions), with a prevalence between 1/8600 and 1/15,000 births [3]. Congenital chylothorax typically presents at birth, or within the first week of life. The presentation is one of respiratory distress and the diagnosis is typically confirmed by pleural aspiration of a milky fluid with triglyceride levels >1.1 mmol/L and total cell counts > 1,000 cells per ml with 80% lymphocytes [1-3].
Chylothorax may be either acquired or congenital. Acquired chylothorax is usually due to trauma to the thoracic duct during cardiac or thoracic surgery. Congenital chylothorax is associated with abnormalities of the lymphatic system such as lymphangiomatosis and lymphangiectasia, congenital heart disease, mediastinal malignancies and chromosomal abnormalities (trisomy 21, Turners and Noonan syndromes). Many cases of chylothorax have no clear etiology and are considered as idiopathic congenital chylothorax like the newborn presented here. The mechanism is thought to be either traumatic, with rupture of the thoracic duct by hyperextension of the spinal column or secondary to increased systemic venous pressure during birth, especially in complicated deliveries [1].
In adults, lymphography has been used to define the anatomy, but is not practical in children due to difficulty cannulating lymphatics [1]. For this reason, we used radionuclide lymphoscintigraphy instead. This showed leakage of chyle above the diaphragm on the right side.
Patients with chylothorax may be treated by conservative means or surgery [1,2]. Conservative treatment includes pleural drainage or repeated thoracocentesis and dietary modifications to reduce the flow of chyle through the thoracic duct while waiting for spontaneous healing [1].
This is usually managed by cessation of oral feeds with total parenteral nutrition, followed by re-establishment of feeds using Medium-Chain-Triglycerides (MCT) based milk formulas which are expensive and not easily available in Tunisia. In the present case, we have successfully used a semi elemental formula with 49% MCT fat.
Some case reports have been described regarding the use of octreotide as an alternative treatment to infants not responding to conservative management. Octreotide has a wide range of inhibitory effects on gastrointestinal and endocrine function. Its mechanism of action in treating chylothorax is unclear, but a possibility is reduction of splanchnic vascular tone, eventually leading to a decreased flow of chyle through the thoracic duct [1,2,4].
Surgery should be considered when medical management fails with either excessively prolonged (>3 to 4 weeks) drainage or >10 ml/kg/day or >100 ml/year of age. Some approaches are reported: thoracic duct ligation, pleurodesis and pleura-peritoneal shunts are the most utilized [1,2].
In a retrospective analysis of 23 newborns with chylothorax, 17 were treated conservatively, and 6 with massive chylothorax were treated surgically. Surgical treatment varied, including en masse thoracic duct ligation, mechanical pleurodesis, and application of fibrin glue [5]. The long-term prognosis seems to be favourable if not associated with genetic disorders like the present case [6-8].
Conclusion
Chylothorax is a rare cause of respiratory distress in newborns. Its diagnosis is based on clinical, radiological, and pleural fluid biochemical findings. Conservative therapy is successful in about 80% of reported cases and should so be tried at first [1].
References
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 7568
  • [From(publication date):
    December-2015 - Aug 30, 2016]
  • Breakdown by view type
  • HTML page views : 7517
  • PDF downloads :51
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version